Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Proteins of the cystic fibrosis respiratory tract. Fragmented immunoglobulin G opsonic antibody causing defective opsonophagocytosis.
R B Fick Jr, … , J B Gee, H Y Reynolds
R B Fick Jr, … , J B Gee, H Y Reynolds
Published July 1, 1984
Citation Information: J Clin Invest. 1984;74(1):236-248. https://doi.org/10.1172/JCI111407.
View: Text | PDF
Research Article

Proteins of the cystic fibrosis respiratory tract. Fragmented immunoglobulin G opsonic antibody causing defective opsonophagocytosis.

  • Text
  • PDF
Abstract

In the disease cystic fibrosis (CF), pulmonary infection with Pseudomonas aeruginosa is a common clinical complication that determines most morbidity and almost all excess mortality. We postulated that in this disease a defect in Pseudomonas-reactive IgG antibodies may contribute to chronic Pseudomonas infections. Bronchoalveolar lavages were performed upon 13 patients with CF, 7 patients with chronic bronchitis characterized by recurrent Pseudomonas infections, and 4 normal volunteers. The levels of various proteins important to host defenses and proteases were determined; enzyme inhibition studies were performed. CF respiratory immunoglobulin levels were significantly elevated when compared with both normals and patients with chronic bronchitis (P less than 0.05). Albumin and transferrin levels were decreased in the CF lung fluids. CF elastolytic activity was strikingly elevated (means = 6.02 micrograms/mg total protein) and the inhibitory profile suggested such activity resembled a serine-proteinase. Alpha-1-antitrypsin antigenic levels were not altered in CF respiratory fluids. There was a tendency for the lavage IgG to fall as elastase levels rose (r = -0.29). IgG opsonins for two Pseudomonas immunotypes were isolated with affinity chromatography for functional and immunochemical studies. Bacterial phagocytic rates in the presence of these Pseudomonas-reactive IgG opsonins derived from CF lavage fluid were depressed (0.3% uptake/unit time) when compared with similarly titered positive controls (uptake = 1.3%/unit time, P less than 0.001). Additionally, normal pulmonary macrophage intracellular killing of Pseudomonas was severely altered in the presence of opsonins derived from CF respiratory fluids. At some time points, less than 30% of the bacteria were killed. CF IgG opsonins contain a cleavage fragment (100,000 D, 5S sedimentation coefficient) with antigenic determinants similar to the Fab portion of IgG. The presence of such a fragment was inversely correlated with phagocytic functional activity. Intact IgG comprised as little as 18% of the CF lavage fluid specimens. Aliquots of intact human IgG, when mixed with the CF opsonins, augmented Pseudomonas uptake and improved intracellular killing. Conversely, peptide fragments of IgG opsonins, which are proteolytically derived in vitro, duplicated in our system the defect observed with opsonins derived from CF lung fluids; bacterial uptake was inversely related to the concentration of F(ab')2 and to a greater degree, to Fc present in the opsonic mixture. We concluded that IgG respiratory opsonins are fragmented, inhibiting phagocytosis and serving a permissive role in the chronic Pseudomonas pulmonary infection in the disease CF.

Authors

R B Fick Jr, G P Naegel, S U Squier, R E Wood, J B Gee, H Y Reynolds

×

Total citations by year

Year: 2023 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1989 1988 1987 1986 1985 Total
Citations: 3 5 1 2 4 2 2 1 1 1 3 3 3 3 5 2 5 5 1 3 3 6 8 1 5 7 2 8 11 5 6 12 6 8 7 5 3 158
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (158)

Title and authors Publication Year
Deficient Complement Opsonization Impairs Mycobacterium avium Killing by Neutrophils in Cystic Fibrosis
Lenhart-Pendergrass PM, Malcolm KC, Wheeler E, Rysavy NM, Poch K, Caceres S, Calhoun KM, Martiniano SL, Nick JA
Microbiology spectrum 2023
Diagnosis and Management of Cystic Fibrosis Exacerbations.
Milinic T, McElvaney OJ, Goss CH
Seminars in respiratory and critical care medicine 2023
Subversion of the Complement System by Pseudomonas aeruginosa.
Hastings CJ, Syed SS, Marques CNH
Journal of bacteriology 2023
Alpha-1 antitrypsin deficiency impairs lung antibacterial immunity in mice
Lena Ostermann, Regina Maus, Jennifer Stolper, Lisanne Schütte, Konstantina Katsarou, Srinu Tumpara, Andreas Pich, Christian Mueller, Sabina Janciauskiene, Tobias Welte, Ulrich A. Maus
JCI Insight 2021
Neutrophil Elastase and Chronic Lung Disease
JA Voynow, M Shinbashi
Biomolecules 2021
Pseudomonas aeruginosa elastase (LasB) as a therapeutic target
MJ Everett, DT Davies
Drug Discovery Today 2021
Protein Engineering: Tools and Applications
H Zhao, SY Lee, J Nielsen, G Stephanopoulos
2021
Metabolic analysis of early nonalcoholic fatty liver disease in humans using liquid chromatography-mass spectrometry
C Hu, T Wang, X Zhuang, Q Sun, X Wang, H Lin, M Feng, J Zhang, Q Cao, Y Jiang
Journal of Translational Medicine 2021
Targeting IgG Autoantibodies for Improved Cytotoxicity of Bactericidal Permeability Increasing Protein in Cystic Fibrosis
K McQuillan, F Gargoum, MP Murphy, OJ McElvaney, NG McElvaney, EP Reeves
Frontiers in pharmacology 2020
Targeting airway inflammation in cystic fibrosis
OJ McElvaney, P Wade, M Murphy, EP Reeves, NG McElvaney
Expert Review of Respiratory Medicine 2019
Searching for physiologically relevant in vitro dissolution techniques for orally inhaled drugs
S Radivojev, S Zellnitz, A Paudel, E Fröhlich
International Journal of Pharmaceutics 2019
The impact of alpha-1 antitrypsin augmentation therapy on neutrophil-driven respiratory disease in deficient individuals
D Dunlea, L Fee, T McEnery, NG McElvaney, E Reeves
Journal of inflammation research 2018
Pharmacokinetic and Pharmacodynamic Considerations for the Use of Monoclonal Antibodies in the Treatment of Bacterial Infections
S Wang-Lin, J Balthasar
Antibodies 2018
Adaptation of Staphylococcus aureus to Airway Environments in Patients With Cystic Fibrosis by Upregulation of Superoxide Dismutase M and Iron-Scavenging Proteins
J Treffon, D Block, M Moche, S Reiss, S Fuchs, S Engelmann, D Becher, L Langhanki, A Mellmann, G Peters, BC Kahl
The Journal of Infectious Diseases 2018
A specialized method of sputum collection and processing for therapeutic interventions in cystic fibrosis
OJ McElvaney, C Gunaratnam, EP Reeves, NG McElvaney
Journal of Cystic Fibrosis 2018
Comparison of fluorescence-based methods to determine nanoparticle uptake by phagocytes and non-phagocytic cells in vitro
M Claudia, Ö Kristin, O Jennifer, R Eva, F Eleonore
Toxicology 2017
Neuropeptides in Respiratory Medicine
M Kaliner, P Barnes, G Kunkel, J Baraniuk
2017
Neutrophil plasticity enables the development of pathological microenvironments: implications for cystic fibrosis airway disease
C Margaroli, R Tirouvanziam
Molecular and Cellular Pediatrics 2016
Measurements of Deposition, Lung Surface Area and Lung Fluid for Simulation of Inhaled Compounds
E Fröhlich, A Mercuri, S Wu, S Salar-Behzadi
Frontiers in pharmacology 2016
Alpha-1 proteinase inhibitors for the treatment of alpha-1 antitrypsin deficiency: safety, tolerability, and patient outcomes
S Chotirmall, M Al-Alawi, T McEnery, NG McElvaney
Therapeutics and Clinical Risk Management 2015
Development and application of an inhalation bioaccessibility method (IBM) for lead in the PM10 size fraction of soil
N Boisa, N Elom, JR Dean, ME Deary, G Bird, JA Entwistle
Environment International 2014
Various Approaches to Clinically Related Research Can Yield Helpful Insight. A Personal Perspective
HY Reynolds
American journal of respiratory and critical care medicine 2013
Kendig & Chernick’s Disorders of the Respiratory Tract in Children
SH Abman
Kendig & Chernick’s Disorders of the Respiratory Tract in Children 2012
Mechanisms of immune dysfunction and bacterial persistence in non-cystic fibrosis bronchiectasis
JD Chalmers, AT Hill
Molecular Immunology 2012
Immune Responses in Cystic Fibrosis: Are They Intrinsically Defective?
D Ratner, C Mueller
American journal of respiratory cell and molecular biology 2012
Clinical Significance of Microbial Infection and Adaptation in Cystic Fibrosis
AR Hauser, M Jain, M Bar-Meir, SA McColley
Clinical microbiology reviews 2011
The role of proteases, endoplasmic reticulum stress and SERPINA1 heterozygosity in lung disease and α-1 anti-trypsin deficiency
CM Greene, T Hassan, K Molloy, NG McElvaney
Expert Review of Respiratory Medicine 2011
The role of proteases, endoplasmic reticulum stress andSERPINA1heterozygosity in lung disease and α-1 anti-trypsin deficiency
CM Greene, T Hassan, K Molloy, NG McElvaney
Expert Review of Respiratory Medicine 2011
Neutrophil Elastase, Proteinase 3, and Cathepsin G as Therapeutic Targets in Human Diseases
B Korkmaz, MS Horwitz, DE Jenne, F Gauthier, D Sibley
Pharmacological reviews 2010
Molecular cloning, characterization and in vitro expression of SERPIN B1 of bighorn sheep (Ovis canadensis) and domestic sheep (Ovis aries), and comparison with that of other species
R Subramaniam, RP Dassanayake, J Norimine, WC Brown, DP Knowles, S Srikumaran
Veterinary Immunology and Immunopathology 2010
SerpinB1 in cystic fibrosis airway fluids: quantity, molecular form and mechanism of elastase inhibition
J Cooley, MK Sontag, FJ Accurso, E Remold-O'Donnell
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2010
Pathogenesis and clinical manifestations of chronic colonization by Pseudomonas aeruginosa and its biofilms in the airway tract
H Kobayashi, O Kobayashi, S Kawai
Journal of Infection and Chemotherapy 2009
Usefulness of serum IgG4 in the diagnosis and follow up of autoimmune pancreatitis: A systematic literature review and meta-analysis
AM Morselli-Labate, R Pezzilli
Journal of Gastroenterology and Hepatology 2009
Clinical challenges in managing bronchiectasis
KW TSANG, D BILTON
Respirology 2009
Proteases and cystic fibrosis
JA Voynow, BM Fischer, S Zheng
The International Journal of Biochemistry & Cell Biology 2008
Interfering with extracellular matrix degradation to blunt inflammation
PJ O'Reilly, A Gaggar, JE Blalock
Current Opinion in Pharmacology 2008
Targeting neutrophil elastase in cystic fibrosis
E Kelly, CM Greene, NG McElvaney
Expert Opinion on Therapeutic Targets 2008
Antibodies for the treatment of bacterial infections: current experience and future prospects
C Bebbington, G Yarranton
Current Opinion in Biotechnology 2008
Moraxella -Dependent α 1 -Antichymotrypsin Neutralization: A Unique Virulence Mechanism
T Manolov, TT Tan, A Forsgren, K Riesbeck
American journal of respiratory cell and molecular biology 2008
Cathepsin-G Interferes with Clearance of Pseudomonas aeruginosa from Mouse Lungs
J Sedor, L Hogue, K Akers, S Boslaugh, J Schreiber, T Ferkol
Pediatric Research 2007
Potential therapy for mucus hypersecretion in chronic obstructive pulmonary disease
JA Park, KB Adler
Journal of Organ Dysfunction 2007
Bronchiectasis a Comperhensive Review
NA ., HH .
Trends in Medical Research 2006
Kendig's Disorders of the Respiratory Tract in Children
SH Abman, JM Davis
Kendig's Disorders of the Respiratory Tract in Children 2006
The Prokaryotes
M Dworkin, S Falkow, E Rosenberg, KH Schleifer, E Stackebrandt
2006
Principles of Molecular Medicine
MS Runge, C Patterson
2006
Pathogenesis, etiology and treatment of bronchiectasis
HH AL-Jahdali, AA Shimemeri, N AL-Shirawi
Annals of thoracic medicine 2006
Human Neutrophil Elastase Induces Hypersecretion of Mucin from Well-Differentiated Human Bronchial Epithelial Cells in Vitro via a Protein Kinase Cδ-Mediated Mechanism
JA Park, F He, LD Martin, Y Li, BN Chorley, KB Adler
The American Journal of Pathology 2005
Aerosol treatment with MNEI suppresses bacterial proliferation in a model of chronicPseudomonas aeruginosa lung infection
DE Woods, A Cantin, J Cooley, DM Kenney, E Remold-O'Donnell
Pediatric Pulmonology 2005
Human neutrophil elastase induces hypersecretion of mucin from well-differentiated human bronchial epithelial cells in vitro via a protein kinase C{delta}-mediated mechanism
JA Park, F He, LD Martin, Y Li, BN Chorley, KB Adler
The American Journal of Pathology 2005
Lung Biology in Health and Disease: Cellular and Molecular Mechanisms
E Sapey, R Stockley
Lung Biology in Health and Disease: Experimental Models and Therapeutic Potential 2005
An Immunoproteomic Approach for Identification of Clinical Biomarkers for Monitoring Disease: Application to Cystic Fibrosis
SK Pedersen, AJ Sloane, SS Prasad, LT Sebastian, RA Lindner, M Hsu, M Robinson, PT Bye, RP Weinberger, JL Harry
Molecular & cellular proteomics : MCP 2005
Intravenous immunoglobulin for cystic fibrosis lung disease: a case series of 16 children
IM Balfour-Lynn, U Mohan, A Bush, M Rosenthal
Archives of disease in childhood 2004
Cystic fibrosis
F Ratjen, G Döring
The Lancet 2003
Long-term antibiotics in the management of non-CF bronchiectasis—do they improve outcome?
DJ Evans, M Greenstone
Respiratory Medicine 2003
Chemokines in the Lung: Mechanisms and Consequences
D Riches
Chemokines in the Lung: Mechanisms and Consequences 2003
Treatment of Severe Small Airways Disease in Children with Cystic Fibrosis
A Jaffe, IM Balfour-Lynn
Pediatric Drugs 2002
Bronchiectasis
AF Barker
New England Journal of Medicine 2002
Treatment of Severe Small Airways Disease in Children with Cystic Fibrosis: Alternatives to Corticosteroids
A Jaffe, IM Balfour-Lynn
Pediatric Drugs 2002
Reduced proteolysis of surfactant protein A and changes of the bronchoalveolar lavage fluid proteome by inhaled α1-protease inhibitor in cystic fibrosis
M Griese, C Bredow, P Birrer
Electrophoresis 2001
Phenotype of CF and the effects of possible modifier genes
JD Acton, RW Wilmott
Paediatric Respiratory Reviews 2001
Inhalation of α1-Protease Inhibitor in Cystic Fibrosis does not affect Surfactant Convertase and Surface Activity
M Griese, C Bredow, P Birrer, A Schams
Pulmonary Pharmacology & Therapeutics 2001
Chinks in the Armor of the Airway: Pseudomonas Infection in the Cystic Fibrosis Lung
TW Ferkol, DC Look
American journal of respiratory cell and molecular biology 2001
Interleukin-8 Up-regulation by Neutrophil Elastase Is Mediated by MyD88/IRAK/TRAF-6 in Human Bronchial Epithelium
DE Walsh, CM Greene, TP Carroll, CC Taggart, PM Gallagher, SJ O'Neill, NG McElvaney
The Journal of biological chemistry 2001
Cystische Fibrose
D Reinhardt, M Götz, R Kraemer, MH Schöni
2001
Serine proteinase inhibitor therapy in ?1-antitrypsin inhibitor deficiency and cystic fibrosis
G D�ring
Pediatric Pulmonology 1999
Characterization of immunoglobulin binding factor in sputum from patients with chronic airway diseases
W Ichikawa, F Ogushi, K Tani, K Maniwa, M Kamada, Y Ohmoto, M Sakatani, S Sone
Respirology 1999
The Pseudomonas aeruginosa secretory product pyocyanin inactivates alpha1 protease inhibitor: implications for the pathogenesis of cystic fibrosis lung disease
BE Britigan, MA Railsback, CD Cox
Infection and immunity 1999
Chronic Lung Disease in Early Infancy
D Riley
Chronic Lung Disease in Early Infancy 1999
Recombinant Human Monocyte/Neutrophil Elastase Inhibitor Protects Rat Lungs against Injury from Cystic Fibrosis Airway Secretions
DD Rees, RA Rogers, J Cooley, RJ Mandle, DM Kenney, E Remold-O'Donnell
American journal of respiratory cell and molecular biology 1999
Role of CFTR in Airway Disease
JM Pilewski, RA Frizzell
Physiological reviews 1999
Molecular Biology of the Lung
RA Stockley
1999
The Pseudomonas aeruginosa Secretory Product Pyocyanin Inactivates α1 Protease Inhibitor: Implications for the Pathogenesis of Cystic Fibrosis Lung Disease
EI Tuomanen, BE Britigan, MA Railsback, CD Cox
Infection and immunity 1999
Alpha-1 antitrypsin deficiency alleles and severe cystic fibrosis lung disease
R Mahadeva, S Stewart, D Bilton, DA Lomas
Thorax 1998
New treatments in adult cystic fibrosis
D Bilton, R Mahadeva
Journal of the Royal Society of Medicine 1997
Genetic and Immunologic Aspects of Cystic Fibrosis
BC Hilman
Annals of Allergy Asthma & Immunology 1997
Hepatocyte growth factor and neutrophil elastase in idiopathic pulmonary fibrosis
S Hojo, J Fujita, T Yoshinouchi, H Yamanouchi, T Kamei, I Yamadori, Y Otsuki, N Ueda, J Takahara
Respiratory Medicine 1997
New Treatments in Adult Cystic Fibrosis
D Bilton, R Mahadeva
Journal of the Royal Society of Medicine 1997
The Pediatric Lung
RW Wilmott
1997
Safety of Adenovirus-Mediated Transfer of the Human Cystic Fibrosis Transmembrane Conductance Regulator cDNA to the Lungs of Nonhuman Primates
RW Wilmott, RS Amin, CR Perez, SE Wert, G Keller, GP Boivin, R Hirsch, J Inocencio, P Lu, SF Reising, S Yei, JA Whitsett, BC Trapnell
Human Gene Therapy 1996
Protease cleavage of iron-transferrin augments pyocyanin-mediated endothelial cell injury via promotion of hydroxyl radical formation
RA Miller, GT Rasmussen, CD Cox, BE Britigan
Infection and immunity 1996
Effect of nebulised recombinant DNase on neutrophil elastase load in cystic fibrosis
CM Costello, CM O'Connor, GA Finlay, P Shiels, MX FitzGerald, JP Hayes
Thorax 1996
Effects of Native and Oxidation-Resistant Secretory Leukoprotease Inhibitor on Cystic Fibrosis Sputum: Inhibition of Neutrophil Elastase Activity and of Sputum-Induced Secretion from Porcine Tracheal Submuc
A Schuster, G Hansen, C Zubrod-Eichert, V Wahn
Pediatric Research 1996
Role of Microbial Proteases in Pathogenesis
H Maeda
Microbiology and Immunology 1996
Opportunities for the Use of Aerosolized α1-Antitrypsin for the Treatment of Cystic Fibrosis
ED Allen
Chest 1996
ARDS Acute Respiratory Distress in Adults
TW Evans, C Haslett
1996
Protease-cleaved iron-transferrin augments oxidant-mediated endothelial cell injury via hydroxyl radical formation
RA Miller, BE Britigan
Journal of Clinical Investigation 1995
Effect of high-affinity anti-Pseudomonas aeruginosa lipopolysaccharide antibodies induced by immunization on the rate of Pseudomonas aeruginosa infection in patients with cystic fibrosis
AB Lang, UB Schaad, A Rüdeberg, J Wedgwood, JU Que, E Fürer, SJ Cryz
The Journal of Pediatrics 1995
New perspectives in understanding and management of the respiratory disease in cystic fibrosis
S Suter
European Journal of Pediatrics 1994
Correlation between specific IgG subclass antibodies toPseudomonas aeruginosa and opsonic activity in serum from patients with cystic fibrosis
T Pressler, ET Jensen, F Espersen, SS Pedersen, N Høiby, C Koch
Pediatric Pulmonology 1994
Helicobacter pylori
J Calam
European Journal of Clinical Investigation 1994
Role of interleukin-8 (IL-8) and an inhibitory effect of erythromycin on IL-8 release in the airways of patients with chronic airway diseases
K Oishi, F Sonoda, S Kobayashi, A Iwagaki, T Nagatake, K Matsushima, K Matsumoto
Infection and immunity 1994
Effects of pentoxifylline on sputum neutrophil elastase and pulmonary function in patients with cystic fibrosis: Preliminary observations
SC Aronoff, FJ Quinn, LS Carpenter, WJ Novick
The Journal of Pediatrics 1994
Pseudomonas aeruginosa Infections in Patients with Cystic Fibrosis: New Immunomodulatory Strategies
A Buret
Clinical immunotherapeutics 1994
The Role of Neutrophil Elastase in Chronic Inflammation
G Döring
American journal of respiratory and critical care medicine 1994
Recent Advances in the Treatment of Cystic Fibrosis
RW Wilmott, MA Fiedler
Pediatric Clinics of North America 1994
Pseudomonas aeruginosa-induced lung and pleural injury in sheep. Differential protective effect of circulating versus alveolar immunoglobulin G antibody
JF Pittet, MA Matthay, G Pier, M Grady, JP Wiener-Kronish
Journal of Clinical Investigation 1993
Effector mechanisms of intestinally induced immunity to Pseudomonas aeruginosa in the rat lung: role of neutrophils and leukotriene B4
A Buret, M Dunkley, RL Clancy, AW Cripps
Infection and immunity 1993
Transferrin and lactoferrin undergo proteolytic cleavage in the Pseudomonas aeruginosa-infected lungs of patients with cystic fibrosis
BE Britigan, MB Hayek, BN Doebbeling, RB Fick
Infection and immunity 1993
α 1 -Proteinase Inhibitor, Elastase Activity, and Lung Disease Severity in Cystic Fibrosis
CM O'Connor, K Gaffney, J Keane, A Southey, N Byrne, S O'Mahoney, MX Fitzgerald
American journal of respiratory and critical care medicine 1993
Pharmacokinetics of Recombinant Secretory Leukoprotease Inhibitor Aerosolized to Normals and Individuals with Cystic Fibrosis
NG McElvaney, B Doujaiji, MJ Moan, MR Burnham, MC Wu, RG Crystal
American journal of respiratory and critical care medicine 1993
The Immunoevasive Activities of Pseudomonas aeruginosa : Relevance for Cystic Fibrosis
A Buret, AW Cripps
American journal of respiratory and critical care medicine 1993
Elevated Levels of Serum Mucin-associated Antigen in Adult Patients with Cystic Fibrosis
CB Robinson, WR Martin, JL Ratliff, PV Holland, R Wu, CE Cross
American journal of respiratory and critical care medicine 1993
Pseudomonas aeruginosa as an Opportunistic Pathogen
M Campa, M Bendinelli, H Friedman
1993
Anti-Pseudomonas aeruginosa IgG subclass titers in patients with cystic fibrosis: Correlations with pulmonary function, neutrophil chemotaxis, and phagocytosis
RG Cowan, GB Winnie
Journal of Clinical Immunology 1993
Proteases, Protease Inhibitors and Protease-Derived Peptides
JC Cheronis, JE Repine
1993
Update on Childhood Asthma
MH Schöni, R Kraemer
1993
Neutrophil elastase in respiratory epithelial lining fluid of individuals with cystic fibrosis induces interleukin-8 gene expression in a human bronchial epithelial cell line
H Nakamura, K Yoshimura, NG McElvaney, RG Crystal
Journal of Clinical Investigation 1992
Modulation of airway inflammation in cystic fibrosis. In vivo suppression of interleukin-8 levels on the respiratory epithelial surface by aerosolization of recombinant secretory leukoprotease inhibitor
NG McElvaney, H Nakamura, P Birrer, CA Hébert, WL Wong, M Alphonso, JB Baker, MA Catalano, RG Crystal
Journal of Clinical Investigation 1992
Mucosal immunity toPseudomonas aemginosaalginate in cystic fibrosis
SS Pedersen, H Møller, F Espersen, CH Sørensen, T Jensen, N Høiby
APMIS 1992
Elevation of Plasma Truncated Elastase α1-Proteinase Inhibitor Complexes in Patients with Inflammatory Lung Diseases
J Fujita, H Nakamura, Y Yamagishi, Y Yamaji, T Shiotani, S Irino
Chest 1992
Biochemistry of Pulmonary Emphysema
C Grassi, J Travis, L Casali, M Luisetti
1992
Pseudomonas and neutrophil products modify transferrin and lactoferrin to create conditions that favor hydroxyl radical formation
BE Britigan, BL Edeker
Journal of Clinical Investigation 1991
Respiratory tract colonization withPseudomonas aeruginosa in cystic fibrosis: Correlations between anti-Pseudomonas aeruginosa antibody levels and pulmonary function
GB Winnie, RG Cowan
Pediatric Pulmonology 1991
Aerosol α1 -antitrypsin treatment for cystic fibrosis
NG McElvaney, RC Hubbard, P Birrer, RG Crystal, MS Chernick, MM Frank, DB Caplan
The Lancet 1991
Microbiology of airway disease in patients with cystic fibrosis
PH Gilligan
Clinical microbiology reviews 1991
Extrinsic and intrinsic determinants of the host response in environmental lung disease
K Anderson, C Mcsharry
International Journal of Environmental Health Research 1991
GcGlobulin Functions as a Cochemotaxin in the Lower Respiratory Tract: A Potential Mechanism for Lung Neutrophil Recruitment in Cigarette Smokers
JP Metcalf, AB Thompson, GL Gossman, KJ Nelson, S Koyama, SI Rennard, RA Robbins
American journal of respiratory and critical care medicine 1991
Neutrophil elastase cleaves C3bi on opsonized pseudomonas as well as CR1 on neutrophils to create a functionally important opsonin receptor mismatch
MF Tosi, H Zakem, M Berger
Journal of Clinical Investigation 1990
The immunoglobulin G subclass composition of immune complexes in cystic fibrosis. Implications for the pathogenesis of the Pseudomonas lung lesion
DB Hornick, RB Fick
Journal of Clinical Investigation 1990
Pseudomonas hyperimmune globulin passive immunotherapy for pulmonary exacerbations in cystic fibrosis
JE van Wye, MS Collins, M Baylor, JE Pennington, YP Hsu, V Sampanvejsopa, RB Moss
Pediatric Pulmonology 1990
IgG subclass antibodies to Pseudomonas aeruginosa in sera from patients with chronic Ps. aeruginosa infection investigated by ELISA
T Pressler, SS Pedersen, F Espersen, N Høiby, C Koch
Clinical & Experimental Immunology 1990
Phenotypic conversion of Pseudomonas aeruginosa in cystic fibrosis
M Fegan, P Francis, AC Hayward, GH Davis, JA Fuerst
Journal of clinical microbiology 1990
IgA subclasses in sputum from patients with bronchiectasis
D Burnett, SL Hill, AR Bradwell, RA Stockley
Respiratory Medicine 1990
Selective IgG Subclass Deficiencies and Antibody Responses to Pneumococcal Capsular Polysaccharide Antigen in Adult Community-acquired Pneumonia
B Herer, F Labrousse, M Mordelet-Dambrine, A Durandy, C Offredo-Hemmer, O Ekindjian, J Chretien, G Huchon
American journal of respiratory and critical care medicine 1990
Cystic Fibrosis
RB Moss
Cystic Fibrosis 1990
Cystic Fibrosis
RB Moss
Cystic Fibrosis 1990
Cystic Fibrosis
RB Moss
Cystic Fibrosis 1990
Cystic Fibrosis
RB Moss
Cystic Fibrosis 1990
IgG subclass antibodies to Pseudomonas aeruginosa in sera from patients with chronic Ps. aeruginosa infection investigated by ELISA.
Pressler T, Pedersen SS, Espersen F, Høiby N, Koch C
Clinical & Experimental Immunology 1990
Complement receptor expression on neutrophils at an inflammatory site, the Pseudomonas-infected lung in cystic fibrosis
M Berger, RU Sorensen, MF Tosi, DG Dearborn, G Döring
Journal of Clinical Investigation 1989
Nonopsonic antibodies in cystic fibrosis. Pseudomonas aeruginosa lipopolysaccharide-specific immunoglobulin G antibodies from infected patient sera inhibit neutrophil oxidative responses
I Eichler, L Joris, YP Hsu, JV Wye, R Bram, R Moss
Journal of Clinical Investigation 1989
Lung humoral response toPseudomonas species
RB Fick
European Journal of Clinical Microbiology & Infectious Diseases 1989
Intravenous immune globulin treatment of pulmonary exacerbations in cystic fibrosis
GB Winnie, RG Cowan, NA Wade
The Journal of Pediatrics 1989
Pathogenic potentials of bacterial proteases
H Maeda, A Molla
Clinica Chimica Acta 1989
Pathogenesis of the Pseudomonas Lung Lesion in Cystic Fibrosis
RB Fick
Chest 1989
The role of complement in host defense against Pseudomonas aeruginosa
NL Schiller
Clinical Immunology Newsletter 1988
Immunoglobulin G and Its Function in the Human Respiratory Tract
HY Reynolds
Mayo Clinic Proceedings 1988
Bacterial Species-dependent Inhibition of Human Granulocyte Elastase
AR Nogare, WC Vial, GB Toews
American journal of respiratory and critical care medicine 1988
Pulmonary Macrophage Antimicrobial Activity in Canine Endotoxin Shock and Lung Injury
RF Jacobs, DR Dorsey, AF Tryka, DR Tabor
Experimental Lung Research 1988
Significance of Immunologic Factors in Cystic Fibrosis
B Przyklenk, A Bauernfeind
Scandinavian Journal of Gastroenterology 1988
Immunologic Aspects of Cystic Fibrosis
G Döring, A Albus, N Høiby
Chest 1988
Pulmonary Host Defense: Defects That Lead to Chronic Inflammation of the Airway
DB Hornick
Clinics in Chest Medicine 1988
Pseudomonas aeruginosa and the Airways Disease of Cystic Fibrosis
JS Hata, RB Fick
Clinics in Chest Medicine 1988
Comparison of live and inactivated influenza vaccine in high risk children
JC King, PA Gross, CR Denning, PF Gaerlan, PF Wright, GV Quinnan
Vaccine 1987
Candidacidal factors in murine bronchoalveolar lavage fluid
KM Nugent, RB Fick
Infection and immunity 1987
Penetration of cefotaxime into respiratory secretions
RB Fick, MR Alexander, RA Prince, JE Kasik
Antimicrobial agents and chemotherapy 1987
Pseudomonas aeruginosa adhesins for tracheobronchial mucin
R Ramphal, C Guay, GB Pier
Infection and immunity 1987
Why is pseudomonas the colonizer and why does it persist?
R Ramphal, S Vishwanath
Infection 1987
Host Defense Impairments That May Lead to Respiratory Infections
HY Reynolds
Clinics in Chest Medicine 1987
Bronchiectasis—New Therapeutic Approaches Based on Pathogenesis
RA Stockley
Clinics in Chest Medicine 1987
Oxidative regulation of neutrophil elastase-alpha-1-proteinase inhibitor interactions
PJ Ossanna, ST Test, NR Matheson, S Regiani, SJ Weiss
Journal of Clinical Investigation 1986
Immunologic aspects of surface infections in the lung
P Piedra, PL Ogra
The Journal of Pediatrics 1986
Regulation of Matrix Accumulation
JJ Jeffrey
Regulation of Matrix Accumulation 1986
The interaction of Infection and the Adult Respiratory Distress Syndrome
MS Niederman, AM Fein
Critical Care Clinics 1986
Immunoglobulins in the lung
D Burnett
Thorax 1986
ALTERNATE-DAY PREDNISONE REDUCES MORBIDITY AND IMPROVES PULMONARY FUNCTION IN CYSTIC FIBROSIS
HS Auerbach, JA Kirkpatrick, M Williams, HR Colten
The Lancet 1985
Opsonophagocytic killing activity of rabbit antibody to Pseudomonas aeruginosa mucoid exopolysaccharide
P Ames, D DesJardins, GB Pier
Infection and immunity 1985
Respiratory infections may reflect deficiencies in host defense mechanisms
HY Reynolds
Disease-a-Month 1985

← Previous 1 2 3 … 6 7 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts